Rapidly progressive pneumonia caused by Cryptococcus neoformans in the patient of granulomatosis with polyangiitis

Akihiko Nakabayashi1, Masafumi Seki2, Toru Hirano1

  • 1Department of Respiratory Medicine, Allergy and Rheumatic Diseases, Graduate School of Medicine, Osaka University, Suita City, Osaka, Japan.

Insights

A patient with granulomatosis with polyangiitis developed Cryptococcus neoformans pneumonia. Early diagnosis and antifungal treatment with liposomal amphotericin B and flucytosine were crucial for management.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Rheumatology

Background:

  • Granulomatosis with polyangiitis (GPA) is a rare autoimmune disease affecting small to medium-sized blood vessels.
  • Patients with GPA, especially those on immunosuppressive therapy, are at increased risk for opportunistic infections.
  • Distinguishing infectious pneumonia from GPA exacerbation can be challenging.

Purpose of the Study:

  • To report a case of Cryptococcus neoformans pneumonia in a patient with a history of GPA.
  • To highlight the diagnostic challenges and successful management of this rare coinfection.
  • To emphasize the importance of considering opportunistic infections in immunocompromised patients presenting with respiratory symptoms.

Main Methods:

  • Clinical presentation of cough and back pain in a 57-year-old male with GPA.
  • Initial computed tomography (CT) revealing mild infiltration and nodules, raising suspicion for GPA exacerbation or bacterial pneumonia.
  • Positive serum Cryptococcus neoformans antigen test, worsening chest X-ray findings despite antibiotics, and isolation of C. neoformans from blood and lung tissue confirmed the diagnosis.

Main Results:

  • The patient presented with symptoms suggestive of respiratory infection or GPA flare.
  • Despite initial antibiotic treatment for suspected bacterial pneumonia, the condition worsened.
  • Diagnosis of Cryptococcus neoformans pneumonia was confirmed by positive antigen testing and fungal isolation.
  • Treatment with liposomal amphotericin B (L-AMB) and flucytosine (5-FC) was initiated.

Conclusions:

  • Cryptococcus neoformans pneumonia can mimic or complicate granulomatosis with polyangiitis.
  • Prompt diagnostic workup, including fungal antigen testing and cultures, is essential for accurate diagnosis.
  • Antifungal therapy with L-AMB and 5-FC can be effective in treating C. neoformans pneumonia in immunocompromised patients.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.4K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
57
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.3K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.4K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.3K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K